retatrutide peptide obesity triple hormone receptor agonist Retatrutide—A Game Changer in Pharmacotherapy Triple G Agonists – Retatrutide.
Description
The data on GLP-1 withdrawal suggests roughly 60% of lost weight returns within one year of discontinuing primarily as fat, on a body now carrying less lean muscle than before
10(9):634-644 .HMN30760
These reports prompted regulatory agencies in multiple countries to investigate whether a causal relationship exists between these medications and suicidal thoughts or behaviors
Available at: [3] NAM
